Davoutis, Efstathia;
Gkiafi, Zoi;
Lykoudis, Panagis M;
(2024)
Bringing gut microbiota into the spotlight of clinical research and medical practice.
World Journal of Clinical Cases
, 12
(14)
pp. 2293-2300.
10.12998/wjcc.v12.i14.2293.
Preview |
Text
Bringing gut microbiota into the spotlight of clinical research and medical practice.pdf - Published Version Download (430kB) | Preview |
Abstract
Despite the increasing scientific interest and expanding role of gut microbiota (GM) in human health, it is rarely reported in case reports and deployed in clinical practice. Proteins and metabolites produced by microbiota contribute to immune system development, energy homeostasis and digestion. Exo- and endogenous factors can alter its composition. Disturbance of microbiota, also known as dysbiosis, is associated with various pathological conditions. Specific bacterial taxa and related metabolites are involved in disease pathogenesis and therefore can serve as a diagnostic tool. GM could also be a useful prognostic factor by predicting future disease onset and preventing hospital-associated infections. Additionally, it can influence response to treatments, including those for cancers, by altering drug bioavailability. A thorough understanding of its function has permitted significant development in therapeutics, such as probiotics and fecal transplantation. Hence, GM should be considered as a ground-breaking biological parameter, and it is advisable to be investigated and reported in literature in a more consistent and systematic way.
| Type: | Article |
|---|---|
| Title: | Bringing gut microbiota into the spotlight of clinical research and medical practice |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.12998/wjcc.v12.i14.2293 |
| Publisher version: | http://dx.doi.org/10.12998/wjcc.v12.i14.2293 |
| Language: | English |
| Additional information: | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Keywords: | Gut microbiota, Biomarker, Fecal microbiota transplantation, Dysbiosis, Prebiotics |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10194467 |
Archive Staff Only
 |
View Item |
